Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bagaimana tambang mineral kritis mengancam sumber air di Manggarai, NTT

● Pengelolaan mata air di Manggarai, NTT, melalui kelembagaan adat semula berjalan baik bertahun-tahun.● Tapi kini, sumber air terancam ekspansi tambang yang tumpang tindih dengan wilayah ...

Indonesia kekurangan tenaga ahli kesehatan jiwa, bisakah program Titian jadi solusinya?

● Program Titian memicu polemik karena dinilai tumpang tindih dengan standar psikolog klinis yang sudah ada.● Program ini bisa beralih menjadi pendidikan spesialis klinis yang belum ada di...

Waspadai represi digital menguat lewat RUU Disinformasi dan Propaganda Asing

Definisi propaganda dalam kamus.hermanthos● RUU Penanggulangan Disinformasi dan Propaganda Asing membuka ruang represi, meski ditujukan untuk pencegahan.● RUU ini berpotensi membuat repres...